Robert J. Bitterman - 21 May 2025 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role: Chairman, Pres & CEO, Director
Signature: /s/ Robert J. Bitterman
Issuer symbol: PHIO
Transactions as of: 21 May 2025
Net transactions value: +$7,446
Form type: 4
Filing time: 23 May 2025, 09:04:08 UTC
Previous filing: 13 Sep 2024
Next filing: 10 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bitterman Robert J	Chairman, Pres & CEO, Director	C/O PHIO PHARMACEUTICALS CORP., 11 APEX DR., SUITE 300A, PMB 2006, MARLBOROUGH	/s/ Robert J. Bitterman	23 May 2025	0001304395

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHIO	Common Stock, $0.0001 par value	Purchase	$5,310	+3,000	+15%	$1.77	22,449	21 May 2025	Direct	F1, F2
transaction	PHIO	Common Stock, $0.0001 par value	Purchase	$2,136	+1,200	+5.3%	$1.78	23,649	22 May 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes shares of common stock underlying unvested restricted stock units.
F2	The number of reported securities has been adjusted to reflect prior reverse stock splits.